363-03-006
MRI in Clinical Practice Abstract
Online Adaptive MRI-guided Stereotactic Body Radiotherapy for Spinal Tumors
Accepted
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
Log inReferences
1. Chang, J. H., Gandhidasan, S., Finnigan, R., Whalley, D., Nair, R., Herschtal, A., ... & Siva, S. (2017). Stereotactic ablative body radiotherapy for the treatment of spinal oligometastases. Clinical Oncology, 29(7), e119-e125, PMID: 28237218 DOI: 10.1016/j.clon.2017.02.004. [doi] [pmid]
2. 2. Sahgal, A., Myrehaug, S. D., Siva, S., Masucci, G. L., Maralani, P. J., Brundage, M., ... & Parulekar, W. R. (2021). Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial. The Lancet Oncology, 22(7), 1023-1033, PMID: 34126044 DOI: 10.1016/S1470-2045(21)00196-0 [doi] [pmid]
3. Han, E. Y., Aima, M., Hughes, N., Briere, T. M., Yeboa, D. N., Castillo, P., ... & Vedam, S. (2020). Feasibility of spinal stereotactic body radiotherapy in Elekta Unity® MR-Linac. Journal of Radiosurgery and SBRT, 7(2), 127, PMID: 33282466 PMCID: PMC7717094 [pmid]
Cite this abstract
http://echo.ismrm.org/p/ISMRM2026/363-03-006